214 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

CGEN

Compugen
US$2.17-11.1%106.7%US$194.3mUS$5.00PS5.4xE-6.3%n/a

IMCR

Immunocore Holdings
US$48.986.4%-13.1%US$2.4bUS$86.50PS9.2xE22.2%n/a

DN

Delta 9 Cannabis
CA$0.015-25.0%-72.7%CA$4.4mn/aPE-0.2xS11.8%n/a

AMRN

Amarin
US$0.862.1%-32.4%US$355.4mUS$1.00PS1.3xE47.3%n/a

93M1

MPH Health Care
€33.808.3%106.7%€144.7m€81.00PE2.9xE-15.1%0%

661

Changchun High-Tech Industry (Group)
CN¥104.81-6.6%-34.8%CN¥42.1bCN¥195.35PE9.3xE12.4%4.3%

603259

WuXi AppTec
CN¥42.11-1.5%-37.9%CN¥118.5bCN¥68.33PE13.1xE11.0%2.3%

301301

Yili Chuanning BiotechnologyLtd
CN¥13.30-4.7%42.2%CN¥29.6bCN¥10.60PE26.5xE16.5%1.7%

TIUM.U

Cansortium
US$0.160%113.3%US$47.9mn/aPB5.6xS10.1%n/a

600420

Shanghai Shyndec Pharmaceutical
CN¥11.431.0%-3.7%CN¥15.3bn/aPE18.2xE9.9%0.9%

CRL

Charles River Laboratories International
US$208.44-4.0%3.9%US$10.7bUS$265.60PE24.2xE13.6%n/a

2773

Chengdu Kanghong Pharmaceutical Group
CN¥22.35-1.1%8.0%CN¥20.6bn/aPE18xE14.7%1.7%

CYRX

Cryoport
US$10.28-6.9%-47.7%US$506.4mUS$17.89PS2.3xE34.5%n/a

ALKS

Alkermes
US$23.40-2.6%-20.7%US$4.0bUS$34.27PE6.9xE-13.3%n/a

YOUR

YourWay Cannabis Brands
CA$0.0850%-65.3%CA$23.2mn/aPE6xn/an/a

C4XD

C4X Discovery Holdings
UK£0.1245.9%-16.4%UK£30.3mn/aPE2.9xE-88.3%n/a

AMLX

Amylyx Pharmaceuticals
US$1.72-0.6%-93.2%US$117.0mUS$4.08PB0.4xE16.4%n/a

VNDA

Vanda Pharmaceuticals
US$5.11-2.3%-15.7%US$297.4mUS$5.21PS1.7xE30.9%n/a

524414

Norris Medicines
₹12.25-7.4%2.1%₹122.5mn/aPS2.3xn/an/a

TARA

Protara Therapeutics
US$2.810.4%-3.1%US$57.9mUS$27.80PB1xE0.5%n/a

ENDP.Q

Endo International
US$0.00060%-98.9%US$141.1kn/aPE-0.00006xn/an/a

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.520%-10.1%HK$851.6mn/aPE5.3xn/a35.5%

543500

Evoq Remedies
₹9.48-2.7%-25.9%₹128.9mn/aPE28.5xn/an/a

1889

Sanai Health Industry Group
HK$0.027-3.6%-64.0%HK$103.2mn/aPE5.1xn/a0%
Page 7 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.